Directed differentiation of cholangiocytes from human pluripotent stem cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Biotechnology

• Publication date

  2015-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt.3294PMID 26167630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver disease in cystic fibrosis

  2014cited by this paper
• Liver disease in cystic fibrosis.

  2014cited by this paper
• Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells

  2014cited by this paper
• CCAAT/enhancer binding protein-mediated regulation of TGFβ receptor 2 expression determines the hepatoblast fate decision

  2014cited by this paper
• Decreasing Incidence of Symptomatic Epstein‐Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience

  2013cited by this paper
• The dynamic biliary epithelia: molecules, pathways, and disease.

  2013cited by this paper
• A functional CFTR assay using primary cystic fibrosis intestinal organoids

  2013cited by this paper
• An In Vitro Expansion System for Generation of Human iPS Cell-Derived Hepatic Progenitor-Like Cells Exhibiting a Bipotent Differentiation Potential

  2013cited by this paper
• Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes

  2013cited by this paper
• Mechanism-based corrector combination restores ΔF508-CFTR folding and function

  2013cited by this paper
• Functional Rescue of F508del-CFTR Using Small Molecule Correctors

  2012cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner* ♦

  2012cited by this paper
• Outcomes of liver transplantation for patients with alagille syndrome: The studies of pediatric liver transplantation experience

  2012cited by this paper
• Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein

  2012cited by this paper
• Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.

  2012cited by this paper
• Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets

  2011cited by this paper
• Transcriptomes of the major human pancreatic cell types

  2011cited by this paper
• Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809

  2011cited by this paper
• Biliary differentiation and bile duct morphogenesis in development and disease.

  2011cited by this paper
• In vitro effects of stromal cells expressing different levels of Jagged-1 and Delta-1 on the growth of primitive and intermediate CD34(+) cell subsets from human cord blood.

  2011cited by this paper
• NOTCH2 mutations in Alagille syndrome

  2011cited by this paper
• Human hepatic stem cell and maturational liver lineage biology

  2011cited by this paper
• Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Organogenesis and development of the liver.

  2010cited by this paper
• Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development

  2010cited by this paper
• Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells

  2009cited by this paper
• EOS lentiviral vector selection system for human induced pluripotent stem cells

  2009cited by this paper
• Notch signaling controls liver development by regulating biliary differentiation

  2009cited by this paper
• Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation

  2009cited by this paper
• Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression

  2008cited by this paper
• Liver‐specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice

  2008cited by this paper
• Generation and Regeneration of Cells of the Liver and Pancreas

  2008cited by this paper
• Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood.

  2008cited by this paper
• Identification and targeting of the ROSA26 locus in human embryonic stem cells

  2007cited by this paper
• Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.

  2007cited by this paper
• NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

  2006cited by this paper
• BMP-4 is required for hepatic specification of mouse embryonic stem cell–derived definitive endoderm

  2006cited by this paper
• Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors.

  2005cited by this paper
• Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors.

  2005cited by this paper
• Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors

  2004cited by this paper
• The role of notch signaling in the development of intrahepatic bile ducts.

  2004cited by this paper
• Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts

  2004cited by this paper
• Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.

  2002cited by this paper
• Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

  1997cited by this paper
• Development and Stem Cells Research Article

  year unknowncited by this paper
• Tbx 3 controls the fate of hepatic progenitor cells in liver development by suppressing p 19 ARF expression

  year unknowncited by this paper

• Advances in Internal Organogenesis: Differentiation and Morphogenesis of Human Ventral Cavity Organs

  2026cites this paper
• Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment

  2025cites this paper
• Advances in liver and pancreas organoids: how far we have come and where we go next

  2025cites this paper
• Organoids in Genetic Disorders: from Disease Modeling to Translational Applications

  2025cites this paper
• Reproducible, Scale-Up Production of Human Liver Organoids (HLOs) on a Pillar Plate Platform via Microarray 3D Bioprinting.

  2025cites this paper
• Gallbladder cholangiocyte organoids

  2025cites this paper
• CFTR Gene Regulation in Human Pancreatic Duct, Bile Duct and Sweat Gland Epithelial Cells

  2025cites this paper
• Innovative Construction and Application of Bile Duct Organoids: Unraveling the Complexity of Bile Duct Diseases and Potential Therapeutic Strategies.

  2025cites this paper
• Directed differentiation of human pluripotent stem cells into pancreatobiliary co-progenitor-like population.

  2025cites this paper
• Sound-controlled fluidic processor

  2025cites this paper
• Heterogeneity and plasticity of cholangiocytes in liver injury: a journey from pathophysiology to therapeutic utility

  2025cites this paper
• Applications and limitations of pluripotent stem cell-derived liver organoids

  2025cites this paper
• Cell reprogramming: methods, mechanisms and applications

  2025cites this paper
• Next-Generation Hydrogels for Biliary Organoid Engineering

  2025cites this paper
• Microenvironmental control of the ductular reaction: balancing repair and disease progression

  2025cites this paper
• Bioscaffold guidance drives liver periportal area tubulogenesis in hIPSC organoids

  2025cites this paper
• Stem Cell-Derived Organoids of the Pancreas: Evaluation of Endocrine and Exocrine Modeling Platforms.

  2025cites this paper
• Cell and tissue reprogramming: Unlocking a new era in medical drug discovery

  2025cites this paper
• Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling

  2025cites this paper
• Application of stem cells in the precise diagnosis and treatment of liver diseases

  2025cites this paper
• Placenta-derived factors contribute to human iPSC-liver organoid growth

  2025cites this paper
• Human PSC-derived liver cells and their applications for disease models and drug discovery.

  2025cites this paper
• Toolbox for creating three-dimensional liver models.

  2024cites this paper
• The Construction of Stem Cell-Induced Hepatocyte Model and Its Application in Evaluation of Developmental Hepatotoxicity of Environmental Pollutants

  2024cites this paper
• Cholangiocyte organoids for disease, cancer, and regenerative medicine.

  2024cites this paper
• Research progress and application of liver organoids for disease modeling and regenerative therapy

  2024cites this paper
• Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators

  2024cites this paper
• Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays

  2024cites this paper
• Generation of in vivo-like multicellular liver organoids by mimicking developmental processes: A review

  2024cites this paper
• Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel

  2024cites this paper
• Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies

  2024cites this paper
• Liver organoids: updates on generation strategies and biomedical applications

  2024cites this paper
• Hepatocytes differentiate into intestinal epithelial cells through a hybrid epithelial/mesenchymal cell state in culture

  2024cites this paper
• 3D culture models to study pathophysiology of steatotic liver disease.

  2024cites this paper
• Establishment of human induced pluripotent stem cell-derived hepatobiliary organoid with bile duct for pharmaceutical research use.

  2024cites this paper
• Using Liver Organoids as Models to Study the Pathobiology of Rare Liver Diseases

  2024cites this paper
• Pathophysiology of Cystic Fibrosis Liver Disease

  2024cites this paper
• 3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells

  2024cites this paper
• Building in vitro models for mechanistic understanding of liver regeneration in chronic liver diseases.

  2024cites this paper
• Progress, application and challenges of liver organoids

  2024cites this paper
• Recent research progresses of bioengineered biliary stents

  2024cites this paper
• Ex Vivo Tools and Models in MASLD Research

  2024cites this paper
• Chemically Defined Organoid Culture System for Cholangiocyte Differentiation

  2024cites this paper
• Resistance to CLnA-induced ferroptosis is acquired in Caco-2 cells upon differentiation

  2023cites this paper
• Whole Liver Derived Acellular Extracellular Matrix for Bioengineering of Liver Constructs: An Updated Review

  2023cites this paper
• Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly

  2023cites this paper
• Human hepatic organoids for the analysis of human genetic diseases.

  2023cites this paper
• Kidney Organoid Derived from Human Pluripotent and Adult Stem Cells for Disease Modeling

  2023cites this paper
• Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

  2023cites this paper
• Assessing Tumorigenicity in Stem Cell-Derived Therapeutic Products: A Critical Step in Safeguarding Regenerative Medicine

  2023cites this paper
• Emergence of In Vitro 3D Systems to Model Human Malaria

  2023cites this paper
• Modeling Liver Development and Disease in a Dish

  2023cites this paper
• Investigation on Electrospun and Solvent-Casted PCL-PLGA Blends Scaffolds Embedded with Induced Pluripotent Stem Cells for Tissue Engineering

  2023cites this paper
• Liver three-dimensional cellular models for high-throughput chemical testing.

  2023cites this paper
• Liver organoids: established tools for disease modeling and drug development

  2023influential citation
• Human liver organoids: From generation to applications

  2023cites this paper
• Modelling of cholangiocarcinogenesis by using pluripotent stem cell

  2023cites this paper
• A decade of liver organoids: Advances in disease modeling

  2023cites this paper
• Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy.

  2023cites this paper
• Effect of Valproic Acid on Promoting the Differentiation of Human Embryonic Stem Cells Into Cholangiocyte-Like Cells

  2023cites this paper
• Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations

  2023cites this paper
• Merits and challenges of iPSC-derived organoids for clinical applications

  2023cites this paper
• Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma

  2022cites this paper
• Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

  2022cites this paper
• Organoids and regenerative hepatology

  2022influential citation
• In vitro functional models for human liver diseases and drug screening: beyond animal testing.

  2022cites this paper
• Advancements in MAFLD Modeling with Human Cell and Organoid Models

  2022cites this paper
• Microfluidic Techniques for Next‐Generation Organoid Systems

  2022cites this paper
• Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury

  2022cites this paper
• Senolytic treatment preserves biliary regenerative capacity lost through cellular senescence during cold storage

  2022cites this paper
• Curative Measures for Cystic Fibrosis: A Perspective on Current Stem Cell–Based, Gene, and Small Molecule Therapies

  2022cites this paper
• Modelling metabolic diseases and drug response using stem cells and organoids

  2022cites this paper
• In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations

  2022cites this paper
• Identifying the critical states of complex diseases by the dynamic change of multivariate distribution

  2022cites this paper
• Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells.

  2022cites this paper
• Capybara: A computational tool to measure cell identity and fate transitions.

  2022cites this paper
• Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment.

  2022cites this paper
• Viscoelastic Notch Signaling Hydrogel Induces Liver Bile Duct Organoid Growth and Morphogenesis

  2022cites this paper
• Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells

  2022cites this paper
• Induced pluripotent stem cells for cystic fibrosis

  2022cites this paper
• Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery

  2022cites this paper
• Recent advances in liver organoids and their use in in vitro modeling of non-alcoholic fatty liver disease

  2022cites this paper
• Cellular therapies in liver and pancreatic diseases.

  2022cites this paper
• Bioengineering Liver Organoids for Diseases Modelling and Transplantation

  2022cites this paper
• Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis

  2022influential citation
• Defense of COVID-19 by Human Organoids

  2021cites this paper
• The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update

  2021influential citation
• Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening

  2021cites this paper
• Decellularized liver extracellular matrix for iPSC-based liver engineering

  2021cites this paper
• ADVANCED PRECLINICAL MODELS FOR EVALUATION OF DRUG INDUCED LIVER INJURY - CONSENSUS STATEMENT BY THE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK [PRO-EURO-DILI-NET].

  2021cites this paper
• A multimodal iPSC platform for cystic fibrosis drug testing

  2021cites this paper
• The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review

  2021influential citation
• A new platform for high-throughput therapy testing on iPSC-derived, immature airway from Cystic Fibrosis Patients

  2021cites this paper
• Liver Organoids: Formation Strategies and Biomedical Applications

  2021cites this paper
• Organoids: a novel modality in disease modeling

  2021cites this paper
• Induced pluripotent stem cells in liver disease

  2021cites this paper
• Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids.

  2021cites this paper
• Liver organoid as a 3D in vitro model for drug validation and toxicity assessment.

  2021cites this paper
• Directing Cholangiocyte Morphogenesis in Natural Biomaterial Scaffolds

  2021cites this paper
• Engineering co-emergence in organoid models

  2021cites this paper